Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
J Biomed Mater Res ; 49(4): 534-41, 2000 Mar 15.
Article in English | MEDLINE | ID: mdl-10602087

ABSTRACT

The quality of articular cartilage engineered using a cell-polymer construct depends, in part, on the chemical composition of the biomaterial and whether that biomaterial can support the chondrocytic phenotype. Acknowledging the supportive influence of tissue-specific matrix molecules on the chondrocytic phenotype, we have combined chondroitin sulfate-A (CSA) and chitosan, a glycosaminoglycan (GAG) analog, to develop a novel biomaterial to support chondrogenesis. Chitosan is a polycationic repeating monosaccharide of beta-1,4-linked glucosamine monomers with randomly located N-acetyl glucosamine units. Chitosan may be combined with the polyanionic CSA such that ionic crosslinking results in hydrogel formation. Bovine primary articular chondrocytes, when seeded onto a thin layer of CSA-chitosan, form discrete, focal adhesions to the material and maintain many characteristics of the differentiated chondrocytic phenotype, including round morphology, limited mitosis, collagen type II, and proteoglycan production. Our findings suggest CSA-chitosan may be well suited as a carrier material for the transplant of autologous chondrocytes or as a scaffold for the tissue engineering of cartilage-like tissue.


Subject(s)
Biocompatible Materials , Cartilage, Articular/cytology , Cartilage, Articular/physiology , Chitin/analogs & derivatives , Chondroitin Sulfates , Collagen/biosynthesis , Animals , Biocompatible Materials/pharmacology , Biodegradation, Environmental , Cartilage, Articular/ultrastructure , Cattle , Cell Division/drug effects , Cells, Cultured , Chitosan , Fibroblasts/cytology , Kinetics , Metacarpophalangeal Joint , Microscopy, Electron, Scanning , Polystyrenes , Sulfates/metabolism , Surface Properties
2.
Biol Reprod ; 61(1): 8-13, 1999 Jul.
Article in English | MEDLINE | ID: mdl-10377025

ABSTRACT

Nitric oxide (NO) synthase (NOS) is active in the gravid uterus, and its activity decreases prior to the onset of parturition. We tested the hypothesis that NO helps maintain uterine quiescence by suppressing the expression of genes necessary for parturition. Pregnant rats (18 days gestation) were treated with inducible NOS (iNOS) inhibitor N-iminoethyl-L-lysine (NIL) or endothelial NOS inhibitor nitro-L-arginine methyl ester (L-NAME); 24 h later, uteri were analyzed for myometrial connexin 43 (Cx43) protein by immunoblotting and mRNA by Northern analysis. Myometrial oxytocin receptors (OTR) were measured by radioligand binding, and decidual prostaglandin H synthase (PGHS) protein by immunoblotting. Uterine NOS blockade was verified by NOS activity assay. We found that NIL, but not L-NAME, significantly increased myometrial Cx43 protein to parturitional levels with treatment at 19 but not 17 days gestation. Steady state mRNA concentrations were not changed at 24 h. NOS inhibition did not increase the concentrations of OTR, or PGHS protein, nor did it decrease maternal serum progesterone. We conclude that endogenous uterine NO from iNOS suppresses myometrial Cx43 gap junction protein expression during rat pregnancy. Although the exact mechanism is unknown, an increase of uterine wall stretch due to inhibition of relaxation could account for increased Cx43 gene transcription.


Subject(s)
Connexin 43/genetics , Gene Expression/drug effects , Myometrium/metabolism , Nitric Oxide/pharmacology , Animals , Enzyme Inhibitors/pharmacology , Female , Gestational Age , Lysine/analogs & derivatives , Lysine/pharmacology , Myometrium/chemistry , NG-Nitroarginine Methyl Ester/pharmacology , Nitric Oxide Synthase/antagonists & inhibitors , Pregnancy , Prostaglandin-Endoperoxide Synthases/analysis , RNA, Messenger/analysis , Rats , Rats, Sprague-Dawley , Receptors, Oxytocin/analysis
3.
Osteoarthritis Cartilage ; 7(1): 71-80, 1999 Jan.
Article in English | MEDLINE | ID: mdl-10367016

ABSTRACT

OBJECTIVE: Experimental findings have suggested that the metabolic activities of articular cartilage can be influenced by mechanical stimuli. Our mathematical analysis predicted that cyclic compressive loading may create periods of intermittent sub-ambient hydrostatic pressure within the cartilage extracellular matrix. Based on this mathematical analysis, the present study was aimed to investigate whether the intermittent sub-ambient hydrostatic pressure, created in the cartilage extracellular matrix during cyclic compression, has a stimulative effect on the biosynthesis of chondrocytes. METHOD: In order to test this hypothesis, the present study developed a custom-designed sub-ambient pressure generator to subject a monolayer culture of chondrocytes to an intermittent sub-ambient pressure. Using this pressure generator, the monolayer chondrocyte culture system was analyzed for 35S-sulfate and 3H-proline incorporation rates for biosynthesis of proteoglycan and collagenous/noncollagenous protein molecules, respectively. Northern analyses for aggrecan and type II collagen mRNAs were also performed. RESULTS: It was found that the intermittent sub-ambient pressure produced a 40% increase in proteoglycan and a 17% increase in non-collagenous protein synthesis during the pressurization period (P < 0.05). The collagenous protein synthesis was not affected by the intermittent sub-ambient pressure regimen used in this study. After the intermittent sub-ambient pressurization, the metabolic activities of the chondrocytes returned to normal (control level). The intermittent sub-ambient pressure also produced an increase in the mRNA signals for aggrecan. Therefore, we conclude that intermittent sub-ambient pressure may be one of the potential mechanical stimulators of chondrocytes in articular cartilage during dynamic compression.


Subject(s)
Cartilage, Articular/cytology , Chondrocytes/metabolism , Extracellular Matrix Proteins , Aggrecans , Animals , Biomechanical Phenomena , Cartilage, Articular/metabolism , Cattle , Cell Culture Techniques , Chondroitin Sulfate Proteoglycans/biosynthesis , Chondroitin Sulfate Proteoglycans/genetics , Collagen/biosynthesis , Collagen/genetics , Hydrostatic Pressure , Lectins, C-Type , Models, Biological , Oxygen/metabolism , Partial Pressure , Proline/metabolism , Proteoglycans/biosynthesis , Proteoglycans/genetics , RNA, Messenger/genetics , Sulfates/metabolism
4.
Biochem J ; 324 ( Pt 1): 305-10, 1997 May 15.
Article in English | MEDLINE | ID: mdl-9164871

ABSTRACT

The addition of human recombinant interleukin-1beta (IL-1beta) to cultures of lapine articular chondrocytes provoked the synthesis of large amounts of NO and reduced the production of type-II collagen. NG-Monomethyl-l-arginine (L-NMA), an inhibitor of NO synthase, strongly suppressed the production of NO and partially relieved the inhibition of collagen synthesis in response to IL-1beta. The NO donor S-nitrosoacetylpenicillamine (SNAP), on the other hand, inhibited collagen production. IL-1 lowered the abundance of Col2A1 mRNA in an NO-independent manner. Collectively, these data indicate that IL-1 suppresses collagen synthesis at two levels: a pretranslational level which is NO-independent, and a translational or post-translational level which is NO-mediated. These effects are presumably specific as L-NMA and SNAP had no effect on total protein synthesis or on the distribution of newly synthesized proteins between the cellular and extracellular compartments. Prolyl hydroxylase is an important enzyme in the post-translational processing of collagen, and its regulation and cofactor requirements suggest possible sensitivity to NO. Extracts of cells treated with IL-1 or SNAP had lower prolyl hydroxylase activity, and L-NMA was partially able to reverse the effects of IL-1. These data suggest that prolyl hydroxylase might indeed be a target for NO. Because underhydroxylated collagen monomers fail to anneal into stable triple helices, they are degraded intracellularly. Inhibition of prolyl hydroxylase by NO might thus account for the suppressive effect of this radical on collagen synthesis.


Subject(s)
Cartilage, Articular/metabolism , Collagen/biosynthesis , Nitric Oxide/pharmacology , Penicillamine/analogs & derivatives , Procollagen-Proline Dioxygenase/metabolism , Protein Biosynthesis/drug effects , RNA, Messenger/metabolism , omega-N-Methylarginine/pharmacology , Animals , Cartilage, Articular/drug effects , Cells, Cultured , Collagen/metabolism , Enzyme Inhibitors/pharmacology , Humans , Interleukin-1/pharmacology , Methionine/metabolism , Penicillamine/pharmacology , Proline/metabolism , RNA Processing, Post-Transcriptional , Rabbits , Recombinant Proteins/pharmacology , S-Nitroso-N-Acetylpenicillamine
5.
Placenta ; 17(5-6): 361-5, 1996.
Article in English | MEDLINE | ID: mdl-8829220

ABSTRACT

Xanthine dehydrogenase/oxidase (XDH, EC 1.1.1.204, XO, EC 1.2.3.2) produces uric acid, and in the oxidase form also generates the free radical superoxide. Previous reports failed to demonstrate XDH/XO activity in human placenta. Our objective was to determine evidence of XDH/XO in human placenta. We developed a cDNA probe for human XDH/XO and used it to detect mRNA by Northern hybridization. Immunohistochemical localization of the enzyme in placental tissue was performed using a specific antibody for XDH/XO and ABC-peroxidase. Enzyme activity assay was determined by the conversion of [14C] xanthine to [14C] uric acid. mRNA was detected in all placental samples (n = 4). Villous and non-villous trophoblast cells expressed immunohistochemical staining for XOD (n = 4). Enzyme activity was detected in all placentae (n = 6). Despite previous reports, we found mRNA, XDH/XO protein and enzyme activity in human placenta localized to trophoblast cells. Enzyme activity was much lower than in liver. Several conditions in the maternal-fetal unit could potentially increase XDH/XO activity and conversion of the enzyme to its oxidase form.


Subject(s)
Placenta/enzymology , Xanthine Dehydrogenase/analysis , Xanthine Oxidase/analysis , Animals , Blotting, Northern , DNA Probes , Enzyme Inhibitors/pharmacology , Female , Humans , Immunoenzyme Techniques , Molecular Sequence Data , Pregnancy , RNA, Messenger/analysis , Rats , Trophoblasts/enzymology , Uric Acid/metabolism , Xanthine , Xanthine Dehydrogenase/genetics , Xanthine Dehydrogenase/metabolism , Xanthine Oxidase/genetics , Xanthine Oxidase/metabolism , Xanthines/metabolism
6.
Curr Eye Res ; 12(11): 963-74, 1993 Nov.
Article in English | MEDLINE | ID: mdl-7508359

ABSTRACT

The full-length cDNA of mouse K12 keratin was characterized by sequencing overlapping cDNA clones isolated from a mouse cornea cDNA library. Using Northern blot hybridization, the radio-labeled cDNA hybridized to a 1.9 kb mRNA from adult cornea, but not from other mouse tissues including snout, esophagus, tongue, and skin. During mouse development, corneas do not express K12 mRNA until 4 days postnatal when the epithelium begins to stratify as judged by Northern blot and in situ hybridization. In situ hybridization with 3H-labeled cDNA probe and immunohistochemical studies with antibodies against a synthetic oligo-peptide deduced from rabbit K12 cDNA demonstrate that this mouse K12 keratin is expressed in all cell layers of adult corneal epithelium, and the suprabasal layers, but not the basal layer of the limbal epithelium. Epidermal growth factor (EGF) has been shown to promote epithelium stratification of cultured chicken and human corneas in vitro. To examine whether EGF can promote K12 expression, EGF was administered to neonatal mice. The results indicate that EGF retards K12 expression by corneal epithelial cells, even though it promotes corneal epithelial stratification during mouse development. Taken together, our results demonstrate that the expression of K12 keratin is cornea-specific, differentiation-dependent, and developmentally regulated.


Subject(s)
Cornea/metabolism , Keratins/metabolism , Amino Acid Sequence , Animals , Base Sequence , Blotting, Northern , Cell Differentiation , Cloning, Molecular , Cornea/embryology , DNA/metabolism , Epidermal Growth Factor/administration & dosage , Epithelium/embryology , Epithelium/metabolism , Gene Expression , Immunoenzyme Techniques , In Situ Hybridization , Keratins/genetics , Mice , Molecular Sequence Data , Nucleic Acid Hybridization , RNA, Messenger/genetics , RNA, Messenger/metabolism , Rabbits
7.
Invest Ophthalmol Vis Sci ; 34(9): 2680-9, 1993 Aug.
Article in English | MEDLINE | ID: mdl-7688359

ABSTRACT

PURPOSE: To examine the distribution of the collagen alpha 1(IV) chain and a novel collagen alpha(IV)-related chain in human ocular tissue. METHODS: Two monoclonal antibodies, JK199 and M3F7, against the alpha 1(IV) chain, and one monoclonal antibody, JK132, against a novel alpha(IV)-related chain were used in the avidin biotin peroxidase complex procedure of immunohistochemical studies. In situ hybridization and reverse transcription polymerase chain reaction were used to examine the presence of alpha 1(IV) messenger RNA in corneal epithelium. RESULTS: Our data indicate that monoclonal antibodies JK199 and M3F7 react with most ocular basement membranes, but not with those of corneal epithelium. Similarly, monoclonal antibody JK132 reacts with most basement membranes of ocular tissues, with the exception of the inner limiting membrane of neural retina, Bruch's membrane, and corneal epithelial basement membrane. To examine if the epitopes recognized by the monoclonal antibodies were masked in corneal epithelium, the tissue sections were subjected to limited enzyme digestion, that is, pepsin, hyaluronidase, trypsin, and pronase E, or chemical treatments such as 0.1 N NaOH or 6 M urea. Proteinase treatment removed the JK132 epitope from all ocular basement membranes examined. Despite the pretreatment, corneal epithelial basement membrane was not stained by any of the monoclonal antibodies. However, the alpha 1(IV) messenger RNA was detected in corneal epithelium by in situ hybridization and reverse transcription polymerase chain reaction. Western immunoblotting indicates the presence of the alpha 1(IV) and the novel alpha(IV)-related chain in the basal lamella of corneal epithelium. CONCLUSIONS: The epitopes recognized by JK199, M3F7, and JK132 are masked in basement membrane of corneal epithelium. Based on the tissue distribution and partial amino acid sequences of peptides recognized by JK132, the novel alpha(IV)-related chain differs from other known alpha(IV) chains.


Subject(s)
Collagen/analysis , Eye/chemistry , Aged , Aged, 80 and over , Anterior Eye Segment/chemistry , Antibodies, Monoclonal , Base Sequence , Basement Membrane/chemistry , Blotting, Western , Collagen/genetics , Epitopes/analysis , Humans , Immunoenzyme Techniques , In Situ Hybridization , Middle Aged , Molecular Sequence Data , Polymerase Chain Reaction , RNA, Messenger/analysis
SELECTION OF CITATIONS
SEARCH DETAIL
...